2021/05/11 by Renliang Li, Ping Zhang, Ziyi Hu +3 · 1 citation
Medicine · #Clostridium difficile and Clostridium perfringens research #Helicobacter Infections #Helicobacter pylori #Helicobacter pylori-related gastroenterology studies #Internal medicine #Medicine #Microscopic Colitis
paper · doi:10.1097/md.0000000000025949
openalex publication_date 2021/05/11 · openalex created_date 2021/05/24 · openalex updated_date 2026/08/06
BACKGROUND: Helicobacter pylori (H pylori) infection is a common health problem, which is closely related to peptic ulcers, gastric cancer, and extragastric diseases. Drugs can successfully eradicate it. However, the recurrence of H pylori often occurs after initial eradication. To confirm the global incidence of H pylori reinfection and systematically evaluate its risk factors. METHODS: We will search for the relevant literature through Chinese and English databases, with the retrieval deadline being November 2021. Databases include PubMed, Embase, Web of Science, the Cochrane Library, China National Knowledge Infrastructure, the Chongqing VIP Chinese Science and Technology Periodical Database, Wanfang Database, and China Biomedical Literature Database. Stata14.0 will be used to conduct this systematic review. The preferred reporting items for systematic reviews and meta-analysis protocols statements are followed in this protocol, and the PRISMA statement will be followed in the completed systematic review. RESULTS: The results will be published in a peer-reviewed journal. CONCLUSIONS: This systematic review will provide evidence regarding the rate of H pylori reinfection and its risk factors after successful eradication. It can guide the management of patients with H pylori infection.